| Product NDC: | 63323-617 |
| Proprietary Name: | Milrinone Lactate |
| Non Proprietary Name: | MILRINONE LACTATE |
| Active Ingredient(s): | 1 mg/mL & nbsp; MILRINONE LACTATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-617 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075936 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020801 |
| Package NDC: | 63323-617-50 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-617-50) > 50 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 63323-617-50 |
| Proprietary Name | Milrinone Lactate |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-617-50) > 50 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 63323-617 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MILRINONE LACTATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20020801 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | MILRINONE LACTATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |